Fundraising Fox

Ambagon Therapeutics

2 known investors

ambagontx.com ↗

Ambagon develops small molecule stabilizers of 14-3-3 protein complexes to modulate disease-related protein interactions, targeting therapeutic areas including cancer, metabolic disorders, neurodegenerative and infectious diseases.

BiotechDeep TechMedical Devices

Investors · 2

Mission BiocapitalSan Francisco · $500K – $500K
Nextech InvestZurich

In the news